EUVIMEDEUVIMED entdecken
Crossref

Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection

Sangeeta Kumari, Neelam Bodhale, Aditya Sarode, Mukesh Kumar Jha, Sagar Bhadange, Surya Prakash Pandey, Sathishkumar Selvaraj, Ajit G Chande, Robin Mukhopadhyaya, Soumya Kanti Ghosh, Shailza Singh, Debasri Mukherjee und 3 weitere

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Sangeeta Kumari und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Centre for Cell Science, Ganeshkhind, Pune 411007, India. Hauptthemen laut MEDLINE: Leishmania major, CD40 Antigens, Mice, Inbred BALB C, Leishmaniasis, Cutaneous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The parasite Leishmania resides as amastigotes within the macrophage parasitophorous vacuoles inflicting the disease Leishmaniasis. Leishmania selectively modulates mitogen-activated protein kinase (MAPK) phosphorylation subverting CD40-triggered anti-leishmanial functions of macrophages. The mechanism of any pathogen-derived molecule induced host MAPK modulation remains poorly understood. Herein, we show that of the fifteen MAPKs, LmjMAPK4 expression is higher in virulent L. major. LmjMAPK4- detected in parasitophorous vacuoles and cytoplasm- binds MEK-1/2, but not MKK-3/6. Lentivirally-overexpressed LmjMAPK4 augments CD40-activated MEK-1/2-ERK-1/2-MKP-1, but inhibits MKK3/6-p38MAPK-MKP-3, phosphorylation. A rationally-identified LmjMAPK4 inhibitor reinstates CD40-activated host-protective anti-leishmanial functions in L. major-infected susceptible BALB/c mice. These results identify LmjMAPK4 as a MAPK modulator at the host-pathogen interface and establish a pathogen-intercepted host receptor signaling as a scientific rationale for identifying drug targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmania majorCD40 AntigensMice, Inbred BALB CLeishmaniasis, CutaneousSignal TransductionMacrophagesAnimalsMiceHumansFemalePhosphorylationHost-Parasite InteractionsMAP Kinase Signaling System

Substanzen

CD40 Antigens

Autor:innen und Institutionen

  • National Centre for Cell Science, Ganeshkhind, Pune 411007, India.
  • National Centre for Cell Science, Ganeshkhind, Pune 411007, India. Electronic address: bhaskar211964@yahoo.com.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Kumari, S., Bodhale, N., Sarode, A., Jha, M. K., Bhadange, S., Pandey, S. P., Selvaraj, S., Chande, A. G., Mukhopadhyaya, R., Ghosh, S. K., Singh, S., Mukherjee, D., Duffin, R., Andrews, P., & Saha, B. (2024). Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112100

Vancouver

Kumari S, Bodhale N, Sarode A, Jha MK, Bhadange S, Pandey SP, et al. Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112100

BibTeX
@article{Kumari2024,
  author = {Kumari, Sangeeta and Bodhale, Neelam and Sarode, Aditya and Jha, Mukesh Kumar and Bhadange, Sagar and Pandey, Surya Prakash and Selvaraj, Sathishkumar and Chande, Ajit G and Mukhopadhyaya, Robin and Ghosh, Soumya Kanti and Singh, Shailza and Mukherjee, Debasri and Duffin, Rebekah and Andrews, Philip and Saha, Bhaskar},
  title = {Leishmania major MAPK4 intercepts and redirects CD40 signaling promoting infection},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112100}
}
Kostenlos starten →